Concepedia
Statistics
Publications
11
Citations
753
H-Index
Active since
2014
Affiliations
Melanoma Institute Australia(Current)
The University of Sydney
Peter MacCallum Cancer Centre
Centenary Institute
Westmead Institute
Dilini Gunatilake is an author at Melanoma Institute Australia specializing in medicine, tumor biology, and cell biology.
Top concepts
MedicineCell BiologyTumor BiologyImmunologyTumor MicroenvironmentChromatinCell DeathDermatologyEpigeneticsCancer Biology
Publications per year
2014–2023
Inducible but Not Constitutive Expression of PD-L1 in Human Melanoma Cells Is Dependent on Activation of NF-κB
Kavitha Gowrishankar, Dilini Gunatilake, Stuart Gallagher et al. · PLoS ONE · 2015 · 220 citations · Full text
Immunology, Immune Regulation, Immunoediting +22
Combining BET and HDAC inhibitors synergistically induces apoptosis of melanoma and suppresses AKT and YAP signaling
Anja Heinemann, Carleen Cullinane, Ricardo De Paoli‐Iseppi et al. · Oncotarget · 2015 · 86 citations · Full text
Targeting activating mutations of EZH2 leads to potent cell growth inhibition in human melanoma by derepression of tumor suppressor genes
Jessamy Tiffen, Dilini Gunatilake, Stuart Gallagher et al. · Oncotarget · 2015 · 82 citations · Full text
Control of <scp>NF</scp>‐<scp>kB</scp> activity in human melanoma by bromodomain and extra‐terminal protein inhibitor <scp>I</scp>‐<scp>BET</scp>151
Stuart Gallagher, Branka Mijatov, Dilini Gunatilake et al. · Pigment Cell & Melanoma Research · 2014 · 81 citations
The Epigenetic Regulator I-BET151 Induces BIM-Dependent Apoptosis and Cell Cycle Arrest of Human Melanoma Cells
Stuart Gallagher, Branka Mijatov, Dilini Gunatilake et al. · Journal of Investigative Dermatology · 2014 · 63 citations · Full text
Chromatin, Cell Regulation, Medicine +10
1–5 of 11